Silva, Mauricio F <br/><br/>
m-RECIST at 1 month and Child A are survival predictors after percutaneous ethanol injection of hepatocellular carcinoma.  [electronic resource] 

 -  Annals of hepatology   
 - 796-802 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1665-2681 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carcinoma, Hepatocellular--classification<br/>Cohort Studies<br/>Ethanol--therapeutic use<br/>Female<br/>Humans<br/>Injections, Intralesional<br/>Liver Diseases--classification<br/>Liver Neoplasms--classification<br/>Male<br/>Middle Aged<br/>Neoplasms, Multiple Primary--drug therapy<br/>Prognosis<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Solvents--therapeutic use<br/>Survival Rate<br/>Treatment Outcome<br/>Tumor Burden